Renal safety after one year of sofosbuvir-based therapy for chronic hepatitis C: a Brazilian ?real-life? study

Título:

Renal safety after one year of sofosbuvir-based therapy for chronic hepatitis C: a Brazilian ?real-life? study

Autor:

Thalia Medeiros Tito Avelar

Ano:

2018

DOI:

10.1111/jcpt.12697

Revista:

Journal of Clinical Pharmacy and Therapeutics

ISSN:

02694727

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Vascular endothelial growth factor (VEGF) and interleukin-1 receptor antagonist (IL-1Ra) as promising biomarkers for distinguishing active from latent tuberculosis in children and adolescents

Presence and clinical impact of human Herpesvirus-6 infection in patients with moderate to critical Coronavirus disease-19

Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality

Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome

Extracellular Vesicles: Cell-Derived Biomarkers of Glomerular and Tubular Injury

Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers ? a role for MMP-9/TIMP-1

Successful DAA therapy for chronic hepatitis C reduces HLA-DR on monocytes and circulating immune mediators: a long-term follow-up study

Urinary Podocyte-derived Microparticles in Youth with Type 1 and Type 2 diabetes

PBI-4050 via GPR40 activation improves adenine-induced kidney injury in mice

Simultaneous circulation of arboviruses and other congenital infections in pregnant women in Rio de Janeiro, Brazil